The safety of a therapeutic product composed of a combination of stem cell released molecules from adipose mesenchymal stem cells and fibroblasts

AIM: We sought to determine the safety profile of a therapeutic candidate composed of the released molecules from a combination of human adipose-derived mesenchymal stem cells and fibroblasts. Although stem cells, their progenitor cells and the molecules that are released from these cells have some...

Descripción completa

Detalles Bibliográficos
Autores principales: Maguire, Greg, Friedman, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Future Science Ltd 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7421258/
https://www.ncbi.nlm.nih.gov/pubmed/32802397
http://dx.doi.org/10.2144/fsoa-2020-0027

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7421258/
https://www.ncbi.nlm.nih.gov/pubmed/32802397
http://dx.doi.org/10.2144/fsoa-2020-0027

Ejemplares similares